YUM CHINA (09987) increases 1 billion US dollars share repurchase authorization.
China's Yum China Holdings, Inc. (09987) announces that its board of directors has approved an additional $1 billion share repurchase authorization, bringing the total remaining authorization to approximately $1.2 billion.
YUM CHINA (09987) announced that the Board of Directors has approved an increase in the company's share repurchase authorization by $1 billion, with a total remaining authorization of approximately $12 billion.
Under the repurchase authorization, the company may, from time to time, repurchase its ordinary shares in the public markets in the United States and Hong Kong, or through private negotiations, block trades, accelerated share repurchases, and using trading plans under Rule 10b5-1, all within the confines of applicable laws and regulations. The repurchase authorization has no expiration date. Additionally, any repurchases in Hong Kong and the United States will be subject to general repurchase authorizations sought at the company's annual shareholders' meeting held each year, with the most recent general repurchase authorization granted at the annual shareholders' meeting held on May 23, 2025.
Related Articles

HK Stock Market Move | Chinese-funded securities firms' stocks have increased, with the possibility of expanding the gains. Insurance funds are expected to continue to provide incremental support for the equity market. Loosening restrictions on high-quality institutions will help repair valuations.

HK Stock Market Move | INNOCARE (09969) rises more than 3%, expected to submit soon the new drug application for lorlatinib for the treatment of pediatric patients.

JP Morgan: Expect limited impact from new Mexican tariffs on Minth Group (00425), maintain "neutral" rating.
HK Stock Market Move | Chinese-funded securities firms' stocks have increased, with the possibility of expanding the gains. Insurance funds are expected to continue to provide incremental support for the equity market. Loosening restrictions on high-quality institutions will help repair valuations.

HK Stock Market Move | INNOCARE (09969) rises more than 3%, expected to submit soon the new drug application for lorlatinib for the treatment of pediatric patients.

JP Morgan: Expect limited impact from new Mexican tariffs on Minth Group (00425), maintain "neutral" rating.

RECOMMEND

McDonald’s to Evaluate Franchisee Pricing for Customer Value Under Revised Standards
10/12/2025

Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025

Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025


